Table 2.
Primary and secondary efficacy outcomes and safety outcomes.
| Overall | Propensity Score Matched | |||||
|---|---|---|---|---|---|---|
| BMT | BMT + EVT | BMT | BMT + EVT | |||
| n = 133 | n = 270 | p | n = 73 | n = 73 | p | |
| Primary Outcome (n, %) | ||||||
| mRS 0–3 | 45 (33.8) | 87 (26.7) | 0.248 | 29 (41.4) | 31 (43.1) | 0.844 |
| Secondary Outcome (n, %) | ||||||
| mRS 0–2 | 33 (24.8) | 51 (18.9) | 0.323 | 23 (32.9) | 19 (26.4) | 0.398 |
| mRS 0–1 | 18 (13.5) | 26 (9.6) | 0.506 | 14 (20.0) | 9 (12.5) | 0.225 |
| mRS (median, IQR) | 5 (2–6) | 5 (3–6) | 0.284 | 4 (2–6) | 4 (2–5) | 0.962 |
| mRS (median, IQR) | ||||||
| 0–6 h onset to admission6–24 h onset to admission>24 h onset to admissionunknown onset | 5 (3–6) 4 (2–5) 3 (2–6) 6 (4–6) | 5 (3–6) 5 (4–6) 4.5 (2–6) 5 (4–6) | 0.952 0.496 0.517 0.479 | 4 (2–6) 4 (2–5) – | 4 (2–5) 4 (3–6) – | 0.4670.330 – |
| mRS (median, IQR) | ||||||
| <10 NIHSS on admission≥10 NIHSS on admission | 3 (1.75–5) 6 (5–6) | 3 (2–5) 5 (4–6) | 0.3510.037 | 3 (1–5) 5 (5–6) | 3 (1–5) 5 (4–6) | 0.9400.207 |
| mRS (median, IQR) | ||||||
| <70 years≥70 years | 4 (2–6) 5 (4–6) | 5 (2–6) 5 (4–6) | 0.5020.358 | 4 (2–5) 4.5 (2–6) | 4 (2–5) 4 (3–6) | 0.6770.685 |
| Safety outcome (n, %) | ||||||
| Mortality | 44 (33.8) | 94 (36.2) | 0.730 | 18 (24.7) | 14 (19.1) | 0.549 |
| Surgical decompression | 3 (2.3) | 11 (4.1) | 0.336 | 3 (4.1) | 2 (2.7) | 0.999 |
| Pneumonia | 109 (82.0) | 73 (27.0) | 0.047 | 15 (20.5) | 17 (23.3) | 0.842 |
| Brain edema | 7 (5.3) | 24 (8.9) | 0.199 | 5 (6.8) | 5 (6.8) | 1 |
| Intracerebral bleeding | 1 (0.8) | 4 (1.5) | 0.534 | 0 (0) | 2 (2.7) | 0.497 |
| Cerebral arterial embolism | 4 (3.0) | 13 (4.8) | 0.396 | 2 (2.7) | 4 (5.5) | 0.681 |
BMT, best medical treatment; EVT, endovascular thrombectomy; IQR, interquartile range; NIHSS, National Institutes of Health Stroke Scale; mRS, modified rankin scale.